CollabRx to Present at Taglich Brothers 11th Annual Small Cap Equity Conference
San Francisco, CA (PRWEB) April 29, 2014 -- CollabRx, Inc. (Nasdaq CM: CLRX) is pleased to announce that Thomas Mika, Chairman, President & CEO will be presenting at Taglich Brothers 11th Annual Small Cap Equity Conference May 6, 2014. The Conference will take place at the New York Athletic Club, New York City. To get the detailed agenda, request additional information or register, contact Taglich Brothers at 212-779-2971 or visit http://www.TaglichBrothers.com. The entire event will be webcast and a link to the CollabRx presentation, which is sheduled to begin at 3:30 p.m. EDT on May 6, 2014, can be found on the company’s website at http://www.collabrx.com.
About CollabRx
CollabRx, Inc. (NASDAQ: CLRX) is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world’s knowledge on genomics-based medicine with specific insights from the nation’s top cancer experts, starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com.
About Taglich Brothers
Taglich Brothers, Inc. is a full-service broker dealer focused exclusively on microcap companies. The Company defines the microcap segment of the equity market as companies with less than $250 million in market capitalization. Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community.
CollabRx Contacts:
Thomas R. Mika
CollabRx, Inc.
(415) 248-5350
tmika(at)collabrx(dot)com
or
James Carbonara
Hayden IR
646-755-7412
James(at)haydenir(dot)com
Taglich Brothers Contact:
Karen Payne, Symposia Events
212-779-2971
Thomas Mika, CollabRx, Inc., http://www.collabrx.com, +1 415-248-5350, [email protected]
Share this article